canceraccording to the United States Department of Health and Human Services, is a disease by which some cells in the body multiply uncontrollably and spread to other parts of the body. Unfortunately, it is one of the main causes of death in the world.
In fact, in In 2020, almost ten million deaths were attributed to this disease. Regarding new cases, the most common cancers are the following: breast (2.26 million cases), lung (2.21 million cases), colorectal (1.93 million cases) and prostate (1.41 million cases).
Against this background, any advance in the field of cancer medicine is celebrated in style. Currently, it has been achieved take a giant step by developing a drug that would make cancer slow its progress by not being able to reproduce.
Characteristics
Of course, these drugs are also very intensiveso the entire process must be monitored exhaustively, without overlooking even the smallest detail, especially the side effects that may arise.
This is the reason why only one patient has been selected, since the purpose is for possible adverse effects affect as few people as possible. In addition, of course, it must be studied in depth tolerance to the drug of each person who is going to apply it.
More details
To everyone’s surprise, the drug is able to withstand both leukemias and others tumors of a hematological nature such as lymphomas, but also others such as breast cancer, colon cancer or others of this type.
Apparently, it is a product that is ingested through oralthat is, with simple administration. Of course, they are still reflecting on whether it will be supplied accompanied by a chemotherapy treatment, what its requirements…
From the Vall d’Hebron Hospital They have assured that the drug has many years of development ahead of it, but that it must be given value to development and testing in Spanish territory and with Spanish patients. And it’s no wonder.
#drug #cure #cancer #developed #tested #Spain
